References
- Babacan T, Onat AM, Pehlivan Y, Comez G, Tutar E. A case of the Behçet's disease diagnosed by the pannicufits after meso-therapy. Rheumatol Int. 2010;30:1657–9.
- Direskeneli H. Behçet's disease: infectious aetiology, new auto-antigens, and HLA-B51. Ann Rheum Dis. 2001;60:996–1002.
- Beutler B, Cerami A. The biology of cachectin/TNF-A primary mediator of the host response. Annu Rev Immunol. 1989;7:625–55.
- Bouma G, Xia B, Crusius JB, Bioque G, Koutroubakis I, Von Blomberg BM, et al. Distribution of four polymorphisms in the tumor necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol. 1996;103:391–6.
- Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum. 1993;36:1681–90.
- Sayinalp N, Oezcebe GI, Oezdemir 0, Haznedaroglu CH, Dundar S, Kirazfi S. Cytokines in Behçet's disease. J Rheumatol. 1996;23:321–2.
- Mege JL, Dilsen N, Sanguedolace V, Gul A, Bongrand P, Roux H, et al. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A com-parative study with familial Mediterranean fever and healthy subjects. J Rheumatol. 1993;20:1544–9.
- Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR. Resistin messenger-RNA expression is increased by proin-flammatory cytokines in vitro. Biochem Biophys Res Commun. 2003;309:286–90.
- Filková M, Haluzik M, Gay S, Senolt L. The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol. 2009;133:157–70.
- Senolt L, Housa D, Vemerová Z, Jirdsek T, Svobodová R, Veigl D, et al. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis. 2007;66:458–63.
- Yakindag FN, Yakindag A, Batioglu F, Caglayan 0, Kisa U, Ozdemir 0. Evaluation of serum resistin levels in patients with ocular and non-ocular Behget's disease. Can J Ophthalmol. 2008;43:473–5.
- Kim SK, Choe JY, Park SH, Lee SW, Lee GH, Chung WT. Increased insulin resistance and serum resistin in Korean patients with Behget's disease. Arch Med Res. 2010;41:269–74.
- International Study Group for Behçet's Disease (ISGBD). Cri-teria for diagnosis of Behet's disease. Lancet. 1990;335:1078–80.
- Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005;174:5789–95.
- Stejskal D, Adamovska S, Bartek J, Jurakova R, Proskova J. Resistin-concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003;147: 63–9.
- Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis inhu-mans. Circulation. 2005;111:932–9.
- Axelsson J, Bergsten A, Qureshi AR, Heimbfirger 0, Bárány P, Lönnqvist F, et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int. 2006;69:596–604.
- Bo S, Gambino R, Pagani A, Guidi S, Gentile L, Cassader M, et al. Relationships between human serum resistin, inflammatory markers and insulin resistance. Int J Obes (Lond). 2005;29: 1315–20.
- Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A. Circulating adiponectin and resistin levels in relation tometabolic factors, inflammatory markers, and vascular reactivityin diabetic patients and subjects at risk for diabetes. Diabetes Care. 2004;27:2450–7.
- Al-Daghri N, Chetty R, McTernan PG, Al-Rubean K, Al-Attas 0, Jones AF, et al. Serum resistin isassociated with c-reactive pro-tein & LDL cholesterol in type 2diabetes and coronary artery disease in a Saudi population.Cardiovasc Diabetol. 2005;4: 10.
- Gonzalez-Gay MA, Garcia-Unzueta MT, Gonzalez-Juanatey C, Miranda-Filloy JA, Vazquez-Rodriguez TR, De Matias JM, et al. Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2008;26:311–6.